GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » YoY EBITDA Growth

Tauns Laboratories (TSE:197A) YoY EBITDA Growth : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tauns Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 0.00%.

Tauns Laboratories's EBITDA per Share for the three months ended in Dec. 2024 was 円0.00.

Tauns Laboratories YoY EBITDA Growth Historical Data

The historical data trend for Tauns Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories YoY EBITDA Growth Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
YoY EBITDA Growth
- -37.83 50.23

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
YoY EBITDA Growth - - - - -

Tauns Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tauns Laboratories's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(79.872-53.166)/ | 53.166 |
=50.23 %

Tauns Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Tauns Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » YoY EBITDA Growth
Comparable Companies
TSE:5889 TSE:262A TSE:7749 TSE:7979 TSE:3154 TSE:3593 TSE:7743 TSE:7775 TSE:7702 TSE:3604 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Website
https://www.tauns.co.jp/en
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines